2. 目前Azacytidine以治療骨髓化生不良症候群(MDS)高危險之病患,已有健保給付。此藥作用的機轉為何?
(A) Tyrosine kinase inhibitor
(B) DNA methylation inhibitor
(C) Proteosome inhibitor
(D) Immunomodulator
(E) Vascular endothelial growth factor inhibitor
答案:登入後查看
統計: A(0), B(26), C(3), D(0), E(0) #2013781
統計: A(0), B(26), C(3), D(0), E(0) #2013781